# C-Reactive Protein Levels Predict Improvement in the Liver Functional Reserve by Long-Term Rifaximin Treatment

**Authors:** Kensuke Kitsugi, Kazuhito Kawata, Go Murohisa, Yashiro Yoshizawa, Masaharu Kimata, Yosuke Kobayashi, Shuhei Unno, Hidenao Noritake, Takeshi Chida, Yoshisuke Hosoda

PMC · DOI: 10.3390/diseases13100331 · Diseases · 2025-10-08

## TL;DR

Long-term rifaximin treatment improves liver function in cirrhotic patients, with high C-reactive protein levels predicting better outcomes.

## Contribution

A multicenter study demonstrating that long-term rifaximin improves liver function and identifies CRP as a predictive biomarker.

## Key findings

- Rifaximin improved Child–Pugh and ALBI scores in cirrhotic patients after 12 months.
- High baseline CRP levels predicted improvement in liver functional reserve.
- Albumin levels and hepatic encephalopathy scores improved significantly.

## Abstract

Objectives: Rifaximin is a non-absorbable antibiotic that has an efficacy for hepatic encephalopathy (HE). We previously demonstrated that rifaximin improved liver functional reserve, but this was a single-center study with a limited number of cases, and there were few cases of long-term use. Here, we conducted a multicenter study to evaluate the efficacy of long-term rifaximin administration on the liver functional reserve. Methods: A multicenter retrospective study was conducted on cirrhotic patients who received rifaximin for more than 12 months. We evaluated the efficacy of long-term rifaximin administration on the liver functional reserve. Results: A total of 65 cirrhotic patients were enrolled. Administration of rifaximin for 12 months significantly improved the Child–Pugh score (CPS) and albumin–bilirubin (ALBI) score. Regarding the parameters of the CPS, albumin scores significantly improved in addition to HE scores at 12 months. Univariate and multivariate analysis revealed that high C-reactive protein (CRP) levels (>0.69 mg/dL) at baseline were the predictive factor for improvement in the liver functional reserve. Conclusions: This study suggests that long-term rifaximin administration may improve the liver functional reserve in cirrhotic patients through improvement in albumin levels. CRP levels predict improvement in the liver functional reserve.

## Linked entities

- **Chemicals:** rifaximin (PubChem CID 6436173)
- **Diseases:** hepatic encephalopathy (MONDO:0001711), cirrhosis (MONDO:0005155)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** HE (MESH:D006501), cirrhotic (MESH:D000094724)
- **Chemicals:** Rifaximin (MESH:D000078262), bilirubin (MESH:D001663)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12564473/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12564473/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12564473/full.md

---
Source: https://tomesphere.com/paper/PMC12564473